粉样β积累的轨迹 - 揭示与APOE基因型和认知衰退的关系
Maha Wybitul1, Andreas Buchmann2, Nicolas Langer3
1Institute for Regenerative Medicine, Faculty of Medicine, University of Zurich, Schlieren 8952, Switzerland; Department of Psychology, Faculty of Philosophy, University of Zurich, Zurich 8050, Switzerland.
Neurobiology of aging
|April 9, 2024
概括
APOE ɛ4 载体显示出更高的粉样β (Aβ) 积累. Aβ积累的时间,而不仅仅是数量,影响认知能力下降的风险,特别是在后期积累阶段的非载体中.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物 生物标志物
- 认知老龄化 认知老龄化
背景情况:
- 粉样β (Aβ) 积累是神经退行性疾病的标志,遵循西格形轨迹.
- 无脂蛋白E (APOE) ɛ4等位基因是阿尔茨海默病的主要遗传风险因素,影响Aβ病理.
- 了解Aβ积累阶段如何与APOE ɛ4基因型相互作用,对于预测认知衰退至关重要.
研究的目的:
- 研究不同粉样β (Aβ) 积累阶段对APOE ɛ4基因型与Aβ负担之间的关联的影响.
- 检查这些阶段和基因型如何影响没有痴呆症的个体的认知衰退.
- 确定特定的Aβ积累轨迹和与认知障碍风险增加相关的基因型.
主要方法:
- 长度研究503名没有痴呆症的参与者,使用粉样质子发射断层扫描 (Aβ-PET) 成像超过5.3年.
- 线性混合回归模型用于分析Aβ负载和积累率,考虑不同的阶段 (下降,稳定,增加).
- 在这些阶段,认知衰退的评估与APOE ɛ4载体状态有关.
主要成果:
- APOE ɛ4载体通常表现出更高的Aβ负载和增加的Aβ积累,特别是在Aβ负 (Aβ-) 阶段.
- 考虑到积累阶段后,e4载体和非载体之间Aβ积累的显著差异在Aβ-组中减少.
- 一个值得注意的发现是,在"增加"阶段,非载体中的Aβ积累更高,这表明Aβ沉积的基因型依赖时间线发生了变化.
- 认知能力下降甚至在Aβ-/增加阶段也很明显,突出了早期的病理变化.
结论:
- 粉样β (Aβ) 积累阶段,与APOE ɛ4基因型相结合,显著影响认知能力下降风险.
- 这些发现支持了针对APOE ɛ4载体的早期干预的必要性.
- 监测Aβ-积累的个体,特别是在增加阶段,可能有助于识别那些具有认知衰退高风险的人.
相关概念视频
01:26Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
01:22Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
03:03Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
01:30Cognitive Development During Adulthood
94
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
94